Unable to display view head.php file not found.
 
American Journal of Medicine
 

Hylek - Prevention and Treatment of Venous Thromboembolism - Figure 19
Absolute Contraindication: Prosthetic Heart Valves

An important contraindication concerns patients with a prosthetic heart valve.  All of these new anticoagulants should be avoided in any patients with prosthetic heart valves.  A recently published study[14] looking at dabigatran demonstrated that there are not only more thromboses but also an increased risk of major bleeding with these agents.  So patients with a prosthetic heart valve who develops a DVT cannot be treated with one these new agents and will have to remain on warfarin. Hylek E. Am J Med 2013; published on-line at http://education.amjmed.com/00000. 

References

[14] Van de Werf F, Brueckmann M, Connolly SJ, et al. A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN) randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN). Am Heart J. 2012;163:931-937.

Unable to display view foot.php file not found.